Categories
Pharmaceutical

Demand For RSV Diagnostic Kits & Assays To Remain High And Reach A Valuation Of Us$ 720 Mn By The End Of 2031

Market Snapshot

A newly published industry analysis by Fact.MR estimates revenue from the global respiratory syncytial virus (RSV) diagnostics market to reach US$ 1.3 Bn by 2031, surging at a CAGR of 9%. Demand for RSV diagnostic kits & assays to remain high and reach a valuation of US$ 720 Mn by the end of 2031.

Amongst the many factors credited to accelerating demand for respiratory syncytial virus diagnostics is rising burden of RSV infections, growing demand for molecular diagnostic tests, and increasing approvals of RSV diagnostic kits & assays.

Request Sample   https://www.factmr.com/connectus/sample?flag=S&rep_id=6736

Key Points Covered in Respiratory Syncytial Virus Diagnostics Industry Survey:

  • Market Estimates and Forecasts (2016-2031)
  • Key Drivers and Restraints Shaping Market Growth
  • Segment-wise, Country-wise and Region-wise Analysis
  • Competition Mapping and Benchmarking
  • Market Share Analysis
  • COVID-19 Impact on Demand for Respiratory Syncytial Virus Diagnostics and How to Navigate
  • Recommendation on Key Winning Strategies

Request Customization https://www.factmr.com/connectus/sample?flag=RC&rep_id=6736

Respiratory Syncytial Virus Diagnostics Marketplace Analysis from 2016 to 2020 Vs Demand Outlook for 2021 to 2031

The market for respiratory syncytial virus diagnostics grew from US$ 575 Mn in 2017 to US$ 678 Mn in 2020, and is anticipated to top US$ 1.3 Bn by 2031.

Respiratory syncytial virus is a very common and contagious virus that infects the respiratory track of most children before 1-2 years of age. RSV is the most common cause of bronchiolitis and pneumonia. It also causes respiratory illness in adults, and it can occasionally cause serious infection that needs hospitalization due to breathing complications with bronchiolitis or pneumonia.

For diagnosis, doctors mostly rely on a blood or urine test to look for bacterial infection, chest X-ray for checking any signs of pneumonia, and a test of material scraped out from the patient’s nose or mouth.

Globally, cases of RSV infections are on the rise, which is fuelling demand for rapid diagnostic techniques. According to the Centre of Disease Control and Prevention (CDC), each year, on an average, RSV leads to the hospitalizations of around 1,32,000 – 1,72,000 children below the age of five, and the death of around 14,000 adults above the age of 65, in the United States alone.

As the clinical symptoms of RSV infections are indistinguishable from other respiratory infections, there is growing need for rapid, specific, and sensitive diagnostic techniques.

How are Technological Advancements Aiding Demand Growth of RSV Diagnostics?

New technologies such as filament-based antibody detection assays, thin layer-based amperometric enzyme immunoassay (EIA), and multiplex virus testing are in the final stage of development.

Furthermore, nucleic acid amplification techniques and loop-mediated isothermal amplification will soon be aligned with point of care (POC) devices. This will allow testing to be performed using a one-step kit, which will require only the addition of a patient sample.

Also, the nanoparticle technology, which has the potential to bring about a four-fold improvement in viral detection as compared to RT-PCR, is under development.

Similarly, plasmonic detection techniques such as localized surface plasmon resonance (LSPR) spectroscopy (which uses metallic nanomaterials by exploiting physicochemical peculiarities) are under development with POC detection devices.

This is considered as a major development as methods such as LSPR spectroscopy offer rapid diagnostics and superior sensitivity & affordability as compared to techniques such as surface-enhanced Raman spectroscopy (SERS) and Polymerase Chain Reaction (PCR) coupled with electrospray ionization mass spectrometry (PCR-ESI-MS), which are not cost-effective, cumbersome to perform, and are more limited to research purposes.

Over the next few years, all the above-mentioned technologies are expected to be included in commercialized diagnostic methods. This is considered as a potential growth area for players involved in RSV diagnostics.

Buy Now  https://www.factmr.com/checkout/6736

Key Market Segments Covered in Respiratory Syncytial Virus Diagnostics Industry Research

  • By Technology
    • RSV Molecular Diagnostics
    • RSV Monoclonal Antibodies
    • Immunoassays
    • Differential Light Scattering
    • Artificial Intelligence
    • Liposomes
    • Flow Cytometry
    • Chromatography
    • Diagnostic Imaging
    • Gel Microdroplets
  • By End Users
    • Respiratory Syncytial Virus Diagnostics at Hospitals
    • Respiratory Syncytial Virus Diagnostics at Nursing Homes
    • Respiratory Syncytial Virus Diagnostics at Commercial Laboratories
    • Respiratory Syncytial Virus Diagnostics at Public Health Laboratories

Competitive Landscape

The respiratory syncytial virus diagnostics landscape is highly fragmented in nature. Manufacturers are focusing on technological innovations for speeding up the diagnosis of the respiratory syncytial virus.

Frequent mergers and acquisitions also take place in the market. The acquisition of Sigma Aldrich by Merck KGaA is a classic example.

For More Insights- https://www.biospace.com/article/increasing-awareness-about-oral-hygiene-worldwide-is-creating-prospects-for-growth-in-the-oral-irrigator-market-fact-mr/

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Visit Our Website: https://www.factmr.com
Categories
Pharmaceutical

How are Technological Advancements Aiding Demand Growth of Respiratory Syncytial Virus (RSV) Diagnostics – Exclusive Report by Fact.MR

250 Pages Respiratory Syncytial Virus (RSV) Diagnostics Market Survey by Fact MR, A Leading Business and Competitive Intelligence Provider

According to Fact MR’s recent market research, sales of Respiratory Syncytial Virus (RSV) Diagnostics to swell at propelled CAGR through 2031, as investment towards expansion of healthcare infrastructure continues rising. The goal of the survey is uncover growth opportunities, key trends, growth drivers, and challenges. It also provides recommendations to assist businesses in preparing for unforeseen challenges.

Focus on improving overall patient care will remain a chief growth driver. Besides this, Respiratory Syncytial Virus (RSV) Diagnostics market will continue gaining from increasing willingness among patients and families to spend on advanced healthcare.

To remain ‘ahead’ of your competitors, request for a sample – https://www.factmr.com/connectus/sample?flag=S&rep_id=6736

To offer an in-depth overview, the report provides sales projections for over 20 countries. It also identifies segments exhibiting maximum growth.

Digital Transformation in Healthcare Presenting Opportunities for Respiratory Syncytial Virus (RSV) Diagnostics Market Growth

Healthcare organizations around the world are deploying digital tools to accommodating changing consumer preferences. They are pressing on solving the long-standing challenge pertaining to care model innovation.

Considering this, the focus on making healthcare affordable and more transparent will increase. Adoption of care model innovation in healthcare will have a profound impact on the Respiratory Syncytial Virus (RSV) Diagnostics market.

The market study done by Fact.MR gives exclusive information about how the market will grow. The study identifies crucial trends that are determining the growth of Respiratory Syncytial Virus (RSV) Diagnostics market. This newly published report sheds light on vital dynamics, such as the drivers, restraints, and opportunities for key market players as well as emerging players associated with the production and supply. The latest report by Fact.MR provides detailed Market Analysis of Respiratory Syncytial Virus (RSV) Diagnostics

The report offers actionable and valuable market insights of Respiratory Syncytial Virus (RSV) Diagnostics. The latest report by Fact.MR provides details on the present scenario of the market across various regions along with the historic data and forecast of the market. The report also includes information on the sales and demand of Respiratory Syncytial Virus (RSV) Diagnostics Market across various industries and regions.

This newly published and insightful report sheds light on Market Insights of Respiratory Syncytial Virus (RSV) Diagnostics, key dynamics, their impact on the overall value chain from suppliers to end-users and Growth of Respiratory Syncytial Virus (RSV) Diagnostics Market.

Key Market Segments Covered in Respiratory Syncytial Virus Diagnostics Industry Research

  • By Technology

    • RSV Molecular Diagnostics
    • RSV Monoclonal Antibodies
    • Immunoassays
    • Differential Light Scattering
    • Artificial Intelligence
    • Liposomes
    • Flow Cytometry
    • Chromatography
    • Diagnostic Imaging
    • Gel Microdroplets
  • By End Users

    • Respiratory Syncytial Virus Diagnostics at Hospitals
    • Respiratory Syncytial Virus Diagnostics at Nursing Homes
    • Respiratory Syncytial Virus Diagnostics at Commercial Laboratories
    • Respiratory Syncytial Virus Diagnostics at Public Health Laboratories

Need more information about Report Methodology? Click here- https://www.factmr.com/connectus/sample?flag=RM&rep_id=6736

Respiratory Syncytial Virus (RSV) Diagnostics Market- Scope of Report

A recent study by Fact.MR on the respiratory syncytial virus (RSV) diagnostics market offers a 10-year forecast for 2021 to 2031. The study analyses crucial trends that are currently determining the growth of the market. This report explicates on vital dynamics, such as the drivers, restraints, and opportunities for key market players along with key stakeholders as well as emerging players associated with offering respiratory syncytial virus diagnostics.

The study also provides the dynamics that are responsible for influencing the future status of the market over the forecast period. A detailed assessment of value chain analysis, business execution, cost structure analysis, and supply chain analysis across regional markets has been covered in the report.

A list of prominent companies providing respiratory syncytial virus diagnostics, along with their product portfolios, key strategies, and SWOT analysis, enhances the reliability of this comprehensive research study.

Report Summary

The study offers comprehensive analysis on diverse features, including revenue growth, and revenue generation across the globe.

A comprehensive estimate on the market has been provided through an optimistic scenario as well as a conservative scenario, taking into account revenue from respiratory syncytial virus diagnostics during the forecast period.

Market Size Evaluation

The market has been analysed for each market segment in terms of volume (`000units), and value (US$ Mn).

Market estimates at global and regional levels for RSV diagnostics are available in terms of “US$ Mn” for value and in ‘’’000 units for volume. A Y-o-Y growth contrast on prominent market segments, along with market attractiveness evaluation, has been incorporated in the report. Furthermore, absolute dollar opportunity analysis of all the segments adds prominence to the report. Absolute dollar opportunity plays a crucial role in assessing the level of opportunity that a manufacturer/distributor can look to achieve, along with identifying potential resources, considering the revenue perspective in the global respiratory syncytial virus diagnostics market.

Inspected Assessment on Regional Segments

Key sections have been elaborated in the report, which have helped deliver projections on regional markets. These chapters include regional macros (political, economic and business environment outlook), which are expected to have a momentous influence on the growth of the market during the forecast period.

Country-specific valuation on revenue for respiratory syncytial virus diagnostics have been offered for each regional market, along with market scope estimates and forecasts, and impact analysis of the dynamics of prominence in regions and countries. For all regional markets, Y-o-Y growth estimates have also been incorporated in the report.

Detailed breakup in terms of value for key countries has also been included in the report.

Competition Analysis

The report sheds light on leading providers of respiratory syncytial virus diagnostics, along with their detailed profiles. Essential and up-to-date data related to market performers who are principally engaged in offering respiratory syncytial virus diagnostics have been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits report readers to take preemptive steps in advancing their businesses.

Company profiles have been included in the report, which include essentials such as product portfolios and key strategies, along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all the prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting the market status, and predicting the competition level in the RSV diagnostics market.

Key Takeaways from Market Study

  • Market for respiratory syncytial virus diagnostics to grow 2.3X in value by 2031, and reach a valuation of US$ 1.3 Bn by 2031.
  • RSV diagnostic kits & assays account for more one-third of the global market share.
  • Market for RSV diagnostics in China to top US$ 253 Mn by 2031.
  • Demand for respiratory syncytial virus diagnostics in Canada to increase at CAGR of 7.4%.
  • Market in Japan anticipated to expand at CAGR of 6% from 2021 to 2031.
  • New technological advancements in the field of diagnostics to boost market growth over next 10 years.

“Growing incidence of respiratory syncytial virus infections globally to boost demand for RSV diagnostics over coming years,” says a Fact.MR analyst.

Full Access of this Exclusive Report is Available at- https://www.factmr.com/checkout/6736

respiratory syncytial virusrsv diagnostics market by FactMR
Report Benefits & Key Questions Answered

  • Respiratory Syncytial Virus (RSV) Diagnostics Category and segment level analysis: Fact MR provides a detailed analysis of the factors influencing sales growth across key segments. It highlights key growth drivers and provides useful information for identifying sales prospects at the regional and local level.
  • Respiratory Syncytial Virus (RSV) Diagnostics Historical volume analysis: The report provides a comparison of Respiratory Syncytial Virus (RSV) Diagnostics’s historical sales and projected sales performance for 2021-2031.
  • Respiratory Syncytial Virus (RSV) Diagnostics Manufacturing trend analysis: The report offers a detailed analysis of manufacturing trends in the Respiratory Syncytial Virus (RSV) Diagnostics market. It carefully gauges the impact of changing healthcare needs of key demographics globally
  • Respiratory Syncytial Virus (RSV) Diagnostics Consumption by demographics: The report investigates consumer behavior affecting Respiratory Syncytial Virus (RSV) Diagnostics demand outlook for the assessment period. Effect of their keenness for digital trends on Respiratory Syncytial Virus (RSV) Diagnostics market is carefully analyzed
  • Post COVID consumer spending on Respiratory Syncytial Virus (RSV) Diagnostics: Healthcare industry has been largely influenced by COVID-19 pandemic. The Fact MR Market survey analyzed consumer spending post COVID-19. It assesses how current trends that will influence expenditure on healthcare services, thus affecting Respiratory Syncytial Virus (RSV) Diagnostics market growth.

More Valuable Insights on Respiratory Syncytial Virus (RSV) Diagnostics Market

Fact.MR, in its new report, offers an unbiased Market Analysis of Respiratory Syncytial Virus (RSV) Diagnostics, Sales and Demand of Respiratory Syncytial Virus (RSV) Diagnostics, analyzing forecast statistics through 2019 and beyond. The study reveals growth projections on the basis of various criteria.

Explore Fact.MR’s Comprehensive Coverage on Healthcare Domain:

Fluoro Enzymatic Assays Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Shower Chairs Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Infrared Thermometer Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Read More Trending Reports of Fact.MR-

https://www.biospace.com/article/demand-for-tricuspid-valve-repair-rising-as-congenital-and-rheumatoid-heart-disease-cases-increase-fact-mr/

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:

11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

 

Categories
Pharmaceutical

Demand of Respiratory Syncytial Virus (RSV) Molecular Diagnostics Is Predicted to Grow at a Staggering CAGR of 9% By 2031

Fact.MR, a market research and competitive intelligence provider, projects the global demand for respiratory syncytial virus (RSV) diagnostics to progress positively, surging at a CAGR of above 9% across the 2021-2031 forecast period.

Growing demand for point of care testing of respiratory syncytial virus (RSV)-infected patients and developments in the field of specific markers such as proteomics and genomic are set to accelerate market growth over the coming years.

Increase in the number of patients suffering from RSV infections has raised the overall burden of the disease, and, as such, has fuelled demand for RSV diagnostics globally. Approval of respiratory syncytial virus diagnostic assays & kits is further opening up various opportunities for market players.

To remain ‘ahead’ of your competitors, request a sample
https://www.factmr.com/connectus/sample?flag=S&rep_id=6736

North America dominates the market for respiratory syncytial virus diagnostics due to advanced technologies and innovation across the region, while the market in Asia Pacific is expected to surge at a high growth rate over the forecast period due to increasing burden of RSV infections among the population.

“Growing incidence of respiratory syncytial virus infections globally to boost demand for RSV diagnostics over coming years,” says a Fact.MR analyst.

respiratory syncytial virusrsv diagnostics market by FactMR

Key Market Segments Covered in Respiratory Syncytial Virus Diagnostics Industry Research

  • By Technology

    • RSV Molecular Diagnostics
    • RSV Monoclonal Antibodies
    • Immunoassays
    • Differential Light Scattering
    • Artificial Intelligence
    • Liposomes
    • Flow Cytometry
    • Chromatography
    • Diagnostic Imaging
    • Gel Microdroplets
  • By End Users

    • Respiratory Syncytial Virus Diagnostics at Hospitals
    • Respiratory Syncytial Virus Diagnostics at Nursing Homes
    • Respiratory Syncytial Virus Diagnostics at Commercial Laboratories
    • Respiratory Syncytial Virus Diagnostics at Public Health Laboratories

For Comprehensive Insights Ask An Analyst Here
https://www.factmr.com/connectus/sample?flag=AE&rep_id=6736

Key Takeaways from Market Study

  • Market for respiratory syncytial virus diagnostics to grow 2.3X in value by 2031, and reach a valuation of US$ 1.3 Bn by 2031.
  • RSV diagnostic kits & assays account for more one-third of the global market share.
  • Market for RSV diagnostics in China to top US$ 253 Mn by 2031.
  • Demand for respiratory syncytial virus diagnostics in Canada to increase at CAGR of 7.4%.
  • Market in Japan anticipated to expand at CAGR of 6% from 2021 to 2031.
  • New technological advancements in the field of diagnostics to boost market growth over next 10 years.

Get Customization on this Research Report for specific research solutions:
https://www.factmr.com/connectus/sample?flag=RC&rep_id=6736

Winning Strategy of Key Market Players

Various companies are focusing on organic growth strategies such as product launches, product approvals, and patents. Inorganic growth activities witnessed in the market are acquisitions and partnership & collaborations.

  • Abbott Laboratories
  • Becton
  • Dickinson and Company
  • BioMérieux SA
  • Bio-Rad Laboratories
  • Coris BioConcept
  • DiaSorin Molecular LLC (DiaSorin Inc)
  • F. Hoffmann-La Roche AG
  • Merck KgaA
  • Quest Diagnostics Incorporated
  • Quidel Corporation
  • Thermo Fisher Scientific

For More Insights https://www.biospace.com/article/rising-cases-of-microbial-diseases-add-to-already-high-demand-for-antimicrobial-susceptibility-tests-fact-mr-study/

More Valuable Insights

Fact.MR, in its new offering, presents an unbiased analysis of the respiratory syncytial virus diagnostics market, presenting historical market data (2016-2020) and forecast statistics for the period of 2021-2031.

The study reveals essential insights on the basis of technology (molecular diagnostics, monoclonal antibodies, immunoassay, differential light scattering, artificial intelligence, liposomes, flow cytometry, chromatography, diagnostic imaging, and gel microdroplets) and end user (hospitals, nursing homes, commercial laboratories, and public health laboratories), across major regions of the world (North America, Europe, Asia Pacific, Central & South America, and the Middle East & Africa).

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in the US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have in our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.com